Better treatment for children with brain cancerJuly 23, 2007Young children diagnosed with a malignant type of brain tumour will benefit from research that has taken twelve years to complete. In the search for better ways of treating children with brain cancer the study, carried out by the Children's Cancer and Leukaemia Group at The University of Nottingham, revealed that a significant proportion of children under the age of three, with the brain tumour ependymoma, can be spared, or have delayed, the effects of radiotherapy by using chemotherapy - without compromising their chances of survival. The trial results were published in the Lancet Oncology on 20th July, 2007. Experts in the field of childhood cancer recognise that radiotherapy can be harmful to a young child's developing brain. It can affect IQ, short term memory, growth and puberty. The effective treatment of patients under the age of five remains, say the researchers, one of the more difficult tasks in paediatric oncology.
The trial was funded by Cancer Research UK and the Samantha Dickson Brain Tumour Trust. The study's author, Professor Richard Grundy, from the Children's Brain Tumour Research Centre (CBTRC), at The University of Nottingham said: "We know that radiotherapy can be harmful to the developing brain, so avoiding it, or using it at an older age if needed will hopefully reduce any learning difficulties these children may develop without compromising their chance of a cure". Every year over 450 children are diagnosed with a brain tumour in the UK. Established in 1997 the CBTRC is committed to developing new methods of research to help find a cure whilst minimising the risk of disability. The survival rate for children diagnosed with ependymoma is getting better, but remains unacceptably low. Professor Grundy said: "It is now clear that if we are to improve the outcome for children with ependymoma we need a better understanding of the underlying biology of the disease." Research fellows in Professor Grundy's laboratory at the CBTRC are currently involved in a collaborative project with St Jude Children's Research Hospital in the USA and the Hospital for Sick Children to gain a better understanding of the biology of this disease in the hope of improving outcomes. University of Nottingham | |||||||||||||||||||||
|
Related Brain Cancer Current Events and Brain Cancer News Articles Gulf War research panel finds 1 in 4 veterans suffers from illness caused by toxic exposure At least one in four of the 697,000 U.S. veterans of the 1991 Gulf War suffer from Gulf War illness, a condition caused by exposure to toxic chemicals, including pesticides and a drug administered to protect troops against nerve gas, and no effective treatments have yet been found, a federal panel of scientific experts and veterans concludes in a landmark report released Monday. Do cell phones increase brain cancer risk? Major research initiatives are needed immediately to assess the possibility that using cellular phones may lead to an increased risk of brain tumors. Family history of brain tumors linked to increased risk of brain cancer People with a family history of cancerous brain tumors appear to be at higher risk of developing the same kind of tumors compared to people with no such family history. Cancer-killing viruses influence tumor blood-vessel growth Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body's natural defenses often eliminate the viruses before they can eliminate the tumor. Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas. Researchers discover gene for branchio-oculo-facial syndrome In a collaborative effort, researchers from Boston University School of Medicine (BUSM) have discovered that deletions or mutations within the TFAP2A gene (Activating Enhancer-Binding Protein) result in the distinctive clefting disorder Branchio-Oculo-Facial syndrome (BOFS). Cancer cells spread by releasing 'bubbles', according to an MUHC study A new fundamental mechanism of how tumour cells communicate has just been discovered by the team of Dr. Janusz Rak at the Research Institute of the McGill University Health Centre (MUHC) in collaboration with Dr Guha from the University of Toronto. NovoCure presents results from breast cancer pilot study NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer. Brain study may lead to improved epilepsy treatments Using a rodent model of epilepsy, researchers found one of the body's own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain. Protein protects embryonic stem cells' versatility and self-renewal A protein known as REST blocks the expression of a microRNA that prevents embryonic stem cells from reproducing themselves and causes them to differentiate into specific cell types, scientists at The University of Texas M. D. Anderson Cancer Center report in the journal Nature. More Brain Cancer Current Events and Brain Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||